Manufacturing

Articles

Janssen and MeiraGTx will collaborate on the development and commercialization of gene therapies for treating inherited retinal diseases.

Janssen, MeiraGTx Partner on Eye-Focused Gene Therapy

Horizon and Rutgers University will partner to develop and commercialize new gene editing technology for therapeutic and research applications.

Horizon Discovery, Rutgers Join Forces for Gene Editing

Cell and gene therapy platform company, Locate Bio, has announced that it is set to receive key patents for its IntraStem technology covering the United States and Europe

Locate Bio to be Granted Key US and EU Patents for its Gene Delivery Tech

The companies will offer an IT platform that enhances the visibility and performance of the overall personalized medicine treatment process. 

TrakCel and Quick Partner on Digital Supply Chain for Cell and Gene Therapies

Agilent and other partners are funding development of Tapestri, a single-cell sequencing platform designed to help predict cancer relapse in individual patients and show the efficacy of gene-editing experiments.

Investors Raise $30 Million to Advance “Quality Control” for Gene Editing and Relapse Prediction for Oncology

Updating Research, Development, and Regulatory Models for Gene Therapy

A new facility in California will expand Orchard Therapeutic’s capacity to develop and deliver lentiviral vector and gene-corrected hematopoetic stem cells. 

Orchard Therapeutics Announces New Gene Therapy Manufacturing Facility

Contract development and manufacturing organization (CDMO), Yposkesi, has entered into an agreement in principle with Axovant Sciences.

Yposkesi Announces Agreement in Principle with Axovant to Expand Gene Therapy Manufacturing Capacity

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Moving forward with gene therapy development requires a “quantum leap” in manufacturing capabilities. 

Manufacturing Challenges Limit Gene Therapy Development

Agnes Shanley is senior editor of Pharmaceutical Technology.

Improving the manufacturing of gene therapy vectors will be crucial to making advanced treatments accessible to more patients who need them, agreed panelists at the 2018 Galien Forum.

Manufacturing, Gene Therapies